resiquimod has been researched along with Blast Phase in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alimoghaddam, K; Hadjati, J; Masoumi, F; Memarian, A; Moazzeni, SM; Nourizadeh, M | 1 |
1 other study(ies) available for resiquimod and Blast Phase
Article | Year |
---|---|
Synergistic effect of Toll-like receptor 4 and 7/8 agonists is necessary to generate potent blast-derived dendritic cells in Acute Myeloid Leukemia.
Topics: Adolescent; Adult; Aged; Blast Crisis; Cell Differentiation; Cells, Cultured; Dendritic Cells; Drug Synergism; Female; Humans; Imidazoles; Leukemia, Myeloid, Acute; Lipopolysaccharides; Lymphocyte Activation; Male; Middle Aged; Poly I-C; Toll-Like Receptor 4; Toll-Like Receptor 7; Toll-Like Receptor 8; Young Adult | 2012 |